Abstract:Background There is a critical need for the management of large bone defects. The purpose of this study was to engineer a biomimetic periosteum and to combine this with a macroporous β-tricalcium phosphate (β-TCP) scaffold for bone tissue regeneration. Methods Rat bone marrow-derived mesenchymal stem cells (rBMSCs) were harvested and cultured in different culture media to form undifferentiated rBMSC sheets (undifferentiated medium (UM)) and osteogenic cell sheets (osteogenic medium (OM)). Simultaneously, rBMSCs were differentiated to induced endothelial-like cells (iECs), and the iECs were further cultured on a UM to form a vascularized cell sheet. At the same time, flow cytometry was used to detect the conversion rates of rBMSCs to iECs. The pre-vascularized cell sheet (iECs/UM) and the osteogenic cell sheet (OM) were stacked together to form a biomimetic periosteum with two distinct layers, which mimicked the fibrous layer and cambium layer of native periosteum. The biomimetic periostea were wrapped onto porous β-TCP scaffolds (BP/β-TCP) and implanted in the calvarial bone defects of rats. As controls, autologous periostea with β-TCP (AP/β-TCP) and β-TCP alone were implanted in the calvarial defects of rats, with a no implantation group as another control. At 2, 4, and 8 weeks post-surgery, implants were retrieved and X-ray, microcomputed tomography (micro-CT), histology, and immunohistochemistry staining analyses were performed. Results Flow cytometry results showed that rBMSCs were partially differentiated into iECs with a 35.1% conversion rate in terms of CD31. There were still 20.97% rBMSCs expressing CD90. Scanning electron microscopy (SEM) results indicated that cells from the wrapped cell sheet on the β-TCP scaffold apparently migrated into the pores of the β-TCP scaffold. The histology and immunohistochemistry staining results from in vivo implantation indicated that the BP/β-TCP and AP/β-TCP groups promoted the formation of blood vessels and new bone tissues in the bone defects more than the other two control groups. In addition, micro-CT showed that more new bone tissue formed in the BP/β-TCP and AP/β-TCP groups than the other groups. Conclusions Inducing rBMSCs to iECs could be a good strategy to obtain an endothelial cell source for prevascularization. Our findings indicate that the biomimetic periosteum with porous β-TCP scaffold has a similar ability to promote osteogenesis and angiogenesis in vivo compared to the autologous periosteum. This function could result from the double layers of biomimetic periosteum. The prevascularized cell sheet served a mimetic fibrous layer and the osteogenic cell sheet served a cambium layer of native periosteum. The biomimetic periosteum with a porous ceramic scaffold provides a new promising method for bone healing.

Injectable cartilaginous template transformed BMSCs into vascularized bone

A Cancellous Bone Matrix System with Specific Mineralisation Degrees for Mesenchymal Stem Cell Differentiation and Bone Regeneration

Angiogenic Potential of Human Bone Marrow-Derived Mesenchymal Stem Cells in Chondrocyte Brick-Enriched Constructs Promoted Stable Regeneration of Craniofacial Cartilage.

Engineering bone regeneration with novel cell-laden hydrogel microfiber-injectable calcium phosphate scaffold

Tissue Engineered Bone Via Templated Hbmscs Mineralization and Its Application for Bone Repairing.

A Biphasic, Demineralized, and Decellularized Allograft Bone-Hydrogel Scaffold with a Cell-Based BMP-7 Delivery System for Osteochondral Defect Regeneration.

Preparation of an Injectable and Photocurable Carboxymethyl Cellulose/hydroxyapatite Composite and Its Application in Cranial Regeneration

A Novel Bioimplant Comprising Ad-BMP9-Transfected BMSCs and GelMA Microspheres Produced from Microfluidic Devices for Bone Tissue Engineering

In Vivo Bone Regeneration with Injectable Chitosan/Hydroxyapatite/Collagen Composites and Mesenchymal Stem Cells

Injectable hydrogel delivering bone morphogenetic protein-2, vascular endothelial growth factor, and adipose-derived stem cells for vascularized bone tissue engineering

Bone Regeneration Facilitated by Autologous Bioscaffold Material: Liquid Phase of Concentrated Growth Factor with Dental Follicle Stem Cell Loading

Peri‐Implant Bone Regeneration Using Rhpdgf‐bb, BMSCs, and Β‐tcp in a Canine Model

TISSUE ENGINEERED BONE REGENERATION OF PERIOSTEAL CELLS USING RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 INDUCE

Engineering Vascularized Bone Grafts by Integrating a Biomimetic Periosteum and Β-Tcp Scaffold

An instantly fixable and self-adaptive scaffold for skull regeneration by autologous stem cell recruitment and angiogenesis

An Injectable Continuous Stratified Structurally and Functionally Biomimetic Construct for Enhancing Osteochondral Regeneration.

Engineered three-dimensional bioactive scaffold for enhanced bone regeneration through modulating transplanted adipose derived mesenchymal stem cell and stimulating angiogenesis

Bone Tissue Engineering Using Bone Marrow Stromal Cells and an Injectable Sodium Alginate/gelatin Scaffold.

Engineering biomimetic periosteum with β-TCP scaffolds to promote bone formation in calvarial defects of rats

In Vitro Osteogenic Induction of Bone Marrow Mesenchymal Stem Cells with A Decellularized Matrix Derived from Human Adipose Stem Cells and in Vivo Implantation for Bone Regeneration

Decellularized Cartilage Extracellular Matrix Incorporated Silk Fibroin Hybrid Scaffolds for Endochondral Ossification Mediated Bone Regeneration